Atika Rimainar
A5012242547- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Respiratory Support and Mechanisms
- Intensive Care Unit Cognitive Disorders
- Heparin-Induced Thrombocytopenia and Thrombosis
- Venous Thromboembolism Diagnosis and Management
- Kawasaki Disease and Coronary Complications
- Neuroendocrine Tumor Research Advances
- SARS-CoV-2 detection and testing
- Diabetes Treatment and Management
- Coronary Artery Anomalies
- Mechanical Circulatory Support Devices
University of Indonesia
2024
Oxford University Clinical Research Unit Indonesia
2021-2024
NIHR Clinical Research Network
2021
Nepal Health Research Council
2021
National Institute for Health Research
2021
National Records of Scotland
2021
Intensive Care National Audit & Research Centre
2021
Public Health Scotland
2021
University Hospitals Birmingham NHS Foundation Trust
2021
Oxford University Clinical Research Unit
2021
Background Hydroxychloroquine (HCQ) has proved ineffective in treating patients hospitalised with Coronavirus Disease 2019 (COVID-19), but uncertainty remains over its safety and efficacy chemoprevention. Previous chemoprevention randomised controlled trials (RCTs) did not individually show benefit of HCQ against COVID-19 and, although meta-analysis suggest clinical benefit, guidelines recommend use. Methods findings Healthy adult participants from the healthcare setting, later community,...